PET/MRI在头颈部鳞癌诊断中应用的研究进展

doi:10.13481/j.1671-587x.20190139

摘要/Abstract

摘要： 头颈部鳞癌患者初诊时多已处于肿瘤的中晚期，预后较差，诊断的准确性对于及早发现肿瘤具有重要意义，正电子发射断层显像术（PET）结合磁共振成像（MRI）技术（PET/MRI）的出现为头颈部鳞癌的诊断提供了更为准确的影像学检查手段，为头颈部鳞癌患者的治疗及预后带来极其深远的影响。本文系统地总结PET/MRI技术的发展历程，分析PET/MRI的优势，详细阐述PET/MRI在头颈部鳞癌诊断中的临床应用价值，包括在现有的研究中总结PET/MRI诊断头颈部鳞癌的可行性及诊断价值，肯定PET/MRI相比常规检查手段的诊断优势，探讨PET/MRI在头颈部鳞癌TNM分期中的应用情况，介绍PET/MRI在判断头颈部鳞癌疗效及预后方面的作用，明确PET/MRI鉴别肿瘤的残留及淋巴结转移情况，为头颈部鳞癌的进一步治疗提供诊断支持。同时还分析了目前PET/MRI存在的不足之处，以期取得PET/MRI技术上的进步和发展。

关键词: 正电子发射断层显像术, 磁共振成像, 头颈部肿瘤, 癌,鳞状细胞

中图分类号:

R739.91

王思惠, 王铁君, 张天琪, 田新华. PET/MRI在头颈部鳞癌诊断中应用的研究进展[J]. 吉林大学学报(医学版), 2019, 45(01): 206-210.

参考文献

[1] 赵倩, 李娟, 王荣福.PET/MRⅡ显像技术与其他分子影像技术的比较[J]. 中国医学装备, 2013, 10(1):4-8.
[2] JUDENHOFER M S,WEHRL H F,NEWPORT D F, et al. Simultaneous PET-MRⅡ:a new approach for functional and morphological imaging[J]. Nat Med, 2008, 14(4):459-465.
[3] HANNAH A,SCOTT A M,TOCHON-DANGUY H, et al. Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer[J]. Ann Surg, 2002, 236(2):208-217.
[4] SCHÖDER H, FURY M, LEE N, et al. PET monitoring of therapy response in head and neck squamous cell carcinoma[J]. J Nucl Med, 2009, 50(Suppl 1):74S-88S.
[5] YEN T C,CHANG J T,NG S H, et al. Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET:comparison with head and neck CT/MRI and histopathology[J]. J Nucl Med, 2005, 46(5):775-781.
[6] ISHIKITA T,ORIUCHI N,HIGUCHI T, et al. Additional value of integrated PET/CT over PET alone, in the initial staging and follow up of head and neck malignancy[J]. Ann Nucl Med, 2010, 24(2):77-82.
[7] SYED R,BOMANJI J B,NAGABHUSHAN N, et al. Impact of combined (18)F-FDG PET/CT in head and neck tumours[J]. Br J Cancer, 2005, 92(6):1046-1050.
[8] CHO J K, HYUN S H,CHOI J Y, et al. Prognostic significance of clinical and 18F-FDG PET/CT parameters for post-distant metastasis survival in head and neck squamous cell carcinoma patients[J]. J Surg Oncol, 2016, 114(7):888-894.
[9] XU G Z,GUAN D J,HE Z Y. (18)FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer. A meta-analysis[J]. Oral Oncol, 2011, 47(7):560-565.
[10] CHOI J Y,LEE K S,KWON O J, et al. Improved detection of second primary cancer using integrated[18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging[J]. J Clin Oncol, 2005, 23(30):7654-7659.
[11] WEI J,PEI S,ZHU X. Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma:A meta-analysis[J]. Oral Oncol, 2016, 52:11-17.
[12] CAMMAROTO G,QUARTUCCIO N,SINDONI A, et al. The role of PET/CT in the management of patients affected by head and neck tumors:a review of the literature[J]. Eur Arch Oto-rhino-laryn, 2016, 273(8):1961-1973.
[13] AL-LBRAHEEM A, BUCK A,KRAUSE B J, et al. Clinical applications of FDG PET and PET/CT in head and neck cancer[J]. J Oncol, 2009, 2009:208725.
[14] 吴泳仪, 孙夕林, 申宝忠. PET/MR联合成像的应用[J]. 放射学实践, 2015(6):617-621.
[15] LEIBFARTH S,MÖNNICH D,WELZ S, et al. A strategy for multimodal deformable image registration to integrate PET/MRI into radiotherapy treatment planning[J]. Acta Oncol, 2013, 52(7):1353-1359.
[16] NEWPORT D F. Simultaneous PET-MRI:a new approach for functional and morphological imaging[J]. Nat Med, 2008, 14(4):459-465.
[17] VAROQUAUX A,RAGER O,PONCET A, et al. Detection and quantification of focal uptake in head and neck tumours:(18)F-FDG PET/MRI versus PET/CT[J]. Eur J Nucl Med Mol Imaging, 2014, 41(3):462-475.
[18] VEIT-HAIBACH P,KUHN F P,WIESINGER F, et al. PET-MRI imaging using a tri-modality PET/CT-MRI system with a dedicated shuttle in clinical routine[J]. MAGMA, 2013, 26(1):25-35.
[19] 宋昱垚, 刘荣, 徐白萱,等. 18F-FDG PET-MRI在肝门部胆管腺癌诊断中的价值[J]. 腹腔镜外科杂志, 2017, 22(3):204-207.
[20] AFAQ A,SYED R,BOMANJI J. PET/MRI:a new technology in the field of molecular imaging[J]. Br Med Bull, 2013, 108:159-171.
[21] 王强, 王荣福. PET/MRI新技术应用研究进展[J]. CT理论与应用研究, 2011, 20(3):425-430.
[22] 申强, 李建红, 王荣福. PET-MRI新技术应用进展[J]. 中国医学装备, 2017, 14(4):7-12.
[23] CARRERAS-DELGADO J L,PÉREZDUEÑAS V,RIOLA-PARADA C, et al. PET/MRI:A luxury or a necessity[J]. Rev Esp Med Nucl E Imagen Mol, 2016, 35(5):313-320.
[24] BECKER M,ZAIDI H. Imaging in head and neck squamous cell carcinoma:the potential role of PET/MRI[J]. Br J Radiol, 2014, 87(1036):20130677.
[25] PLATZEK I,BEUTHIEN-BAUMANN B,SCHNEIDER M, et al. PET/MRI in head and neck cancer:initial experience[J]. Eur J Nucl Med Mol Imaging, 2013, 40(1):6-11.
[26] DRZEZGA A,SOUVATZOGLOU M,EIBER M, et al. First clinical experience with integrated whole-body PET/MRI:comparison to PET/CT in patients with oncologic diagnoses[J]. J Nucl Med, 2012, 53(6):845-855.
[27] EIBER M,SOUVATZOGLOU M,PICKHARD A, et al. Simulation of a MRI-PET protocol for staging of head-and-neck cancer including Dixon MRI for attenuation correction[J]. Eur J Radiol, 2012, 81(10):2658-2665.
[28] 白乐, 程勇, 唐勇进,等. 对比分析头颈部鳞状细胞癌PET/CT与PET/MRI特征[J]. 中国医学影像技术, 2017, 33(11):1641-1646.
[29] KUHN F P,HV LINER M,MADER C E, et al. Contrast-enhanced PET/MRI imaging versus contrast-enhanced PET/CT in head and neck cancer:how much MRI information is needed[J]. J Nucl Med, 2014, 55(4):551-558.
[30] BOSS A,STEGGER L,BISDAS S, et al. Feasibility of simultaneous PET/MRI imaging in the head and upper neck area[J]. Eur Radiol, 2011, 21(7):1439-1446.
[31] KANDA T,KITAJIMA K,SUENAGA Y, et al. Value of retrospective image fusion of 18 F-FDG PET and MRI for preoperative staging of head and neck cancer:Comparison with PET/CT and contrast-enhanced neck MRI[J]. Eur J Radiol, 2013, 82(11):2005-2010.
[32] HUANG S H,CHIEN C Y,LIN W C, et al. A comparative study of fused FDG PET/MRI, PET/CT, MRI, and CT imaging for assessing surrounding tissue invasion of advanced buccal squamous cell carcinoma[J]. Clin Nucl Med, 2011,36(7):518-525.
[33] NAKAMOTO Y,TAMAI K,SAGA T, et al. Clinical value of image fusion from MRI and PET in patients with head and neck cancer[J]. Mol Imaging Biol, 2009, 11(1):46-53.
[34] LIAO C T,WANG H M,HUANG S F, et al. PET and PET/CT of the neck lymph nodes improves risk prediction in patients with squamous cell carcinoma of the oral cavity[J]. J Nucl Med, 2011, 52(2):180-187.
[35] KIKUCHI M, YAMANE T,SHINOHARA S, et al. 18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma[J]. Ann Nucl Med, 2011, 25(9):625-633.
[36] QUEIROZ M A,HVLINER M,KUHN F, et al. PET/MRI and PET/CT in follow-up of head and neck cancer patients[J]. Eur J Nucl Med Mol Imaging, 2014, 41(6):1066-1075.
[37] BOLUS N E,GEORGE R,WASHINGTON J, et al. PET/MRI:the blended-modality choice of the future?[J]. J Nucl Med Technol, 2009, 37(2):72-73.